Drug /Cue Interactions In Alcohol-Tobacco Comorbidity
1 other identifier
interventional
244
1 country
1
Brief Summary
The purpose of this study is to determine how people react to different combinations of alcohol and nicotine.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started May 2006
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 8, 2006
CompletedFirst Submitted
Initial submission to the registry
December 31, 2008
CompletedFirst Posted
Study publicly available on registry
January 1, 2009
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
June 20, 2019
CompletedSeptember 6, 2019
September 1, 2019
7.8 years
December 31, 2008
September 5, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Psychophysiological Reactivity Assessment
To assess cravings and psychophysiological reactivity elicited by alcohol, smoking, and neutral cues following acute intake of alcohol and nicotine among individuals across a broad range of alcohol and cigarette use patterns (Study 1).
approximately 5 weeks per participant
Secondary Outcomes (1)
Alcohol Self-administration Assessment
approximately 5 weeks per participant.
Study Arms (4)
Alcohol and Nicotine Group
EXPERIMENTALAlcohol and Nicotine Drug/Cue Interactions
Alcohol Only Group
ACTIVE COMPARATORAlcohol Only Drug/Cue Interactions
Nicotine Only Group
ACTIVE COMPARATORNicotine Only Drug/Cue Interactions
Placebo and Placebo Group
PLACEBO COMPARATORPlacebo Only Drug/Cue Interactions
Interventions
Five research sessions. Session 1: Questionnaires, interviews, computer task, medical evaluation. Sessions 2 - 5: Lab Sessions involving tobacco with brief summary at the end of the last session.
Five research sessions. Session 1: Questionnaires, interviews, computer task, medical evaluation. Sessions 2 - 5: Lab Sessions involving and alcohol with brief summary at the end of the last session.
Five research sessions. Session 1: Questionnaires, interviews, computer task, medical evaluation. Sessions 2 - 5: Lab Sessions involving placebo with brief summary at the end of the last session.
Eligibility Criteria
You may qualify if:
- English speaking persons who exhibit a range of alcohol consumption and smoking patterns.
- Signed written consent form.
You may not qualify if:
- Females who are pregnant, nursing, or not using effective methods of birth control will be excluded from participating.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
H. Lee Moffitt Cancer Center & Research Institute
Tampa, Florida, 33612, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
David Drobes, Ph.D.
H. Lee Moffitt Cancer Center and Research Institute
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 31, 2008
First Posted
January 1, 2009
Study Start
May 8, 2006
Primary Completion
March 1, 2014
Study Completion
June 20, 2019
Last Updated
September 6, 2019
Record last verified: 2019-09